Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 134

1.

Sex Disparity in Survival of Patients With Uveal Melanoma: Better Survival Rates in Women Than in Men in South Korea.

Park SJ, Oh CM, Yeon B, Cho H, Park KH.

Invest Ophthalmol Vis Sci. 2017 Mar 1;58(3):1909-1915. doi: 10.1167/iovs.16-20077.

PMID:
28362882
2.

Clinicopathological Characteristics and Prognosis for Survival after Enucleation of Uveal Melanoma in Chinese Patients: Long-term Follow-up.

Yue H, Qian J, Yuan Y, Zhang R, Bi Y, Meng F, Xuan Y.

Curr Eye Res. 2017 May;42(5):759-765. doi: 10.1080/02713683.2016.1245422. Epub 2016 Dec 2.

PMID:
27911584
3.

Assessment of the effect of iris colour and having children on 5-year risk of death after diagnosis of uveal melanoma: a follow-up study.

Schmidt-Pokrzywniak A, Kalbitz S, Kuss O, Jöckel KH, Bornfeld N, Stang A.

BMC Ophthalmol. 2014 Apr 1;14:42. doi: 10.1186/1471-2415-14-42.

4.

Uveal and conjunctival malignant melanoma in denmark 1943-97: observed and relative survival of patients followed through 2002.

Isager P, Engholm G, Overgaard J, Storm H.

Ophthalmic Epidemiol. 2006 Apr;13(2):85-96.

PMID:
16581612
5.

Survival in patients with uveal melanoma in Europe.

Virgili G, Gatta G, Ciccolallo L, Capocaccia R, Biggeri A, Crocetti E, Lutz JM, Paci E; EUROCARE Working Group.

Arch Ophthalmol. 2008 Oct;126(10):1413-8. doi: 10.1001/archopht.126.10.1413.

PMID:
18852420
6.

Nationwide Incidence of Ocular Melanoma in South Korea by Using the National Cancer Registry Database (1999-2011).

Park SJ, Oh CM, Kim BW, Woo SJ, Cho H, Park KH.

Invest Ophthalmol Vis Sci. 2015 Jul;56(8):4719-24. doi: 10.1167/iovs.15-16532.

PMID:
26207308
7.

Long-term Risk of Melanoma-Related Mortality for Patients With Uveal Melanoma Treated With Proton Beam Therapy.

Lane AM, Kim IK, Gragoudas ES.

JAMA Ophthalmol. 2015 Jul;133(7):792-6. doi: 10.1001/jamaophthalmol.2015.0887.

PMID:
25905597
8.

The prognostic effect of American Joint Committee on Cancer staging and genetic status in patients with choroidal and ciliary body melanoma.

Bagger M, Andersen MT, Andersen KK, Heegaard S, Andersen MK, Kiilgaard JF.

Invest Ophthalmol Vis Sci. 2014 Dec 23;56(1):438-44. doi: 10.1167/iovs.14-15571.

PMID:
25537201
9.

American Joint Committee on Cancer Classification of Uveal Melanoma (Anatomic Stage) Predicts Prognosis in 7,731 Patients: The 2013 Zimmerman Lecture.

Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA.

Ophthalmology. 2015 Jun;122(6):1180-6. doi: 10.1016/j.ophtha.2015.01.026. Epub 2015 Mar 24.

PMID:
25813452
10.

Very long-term prognosis of patients with malignant uveal melanoma.

Kujala E, Mäkitie T, Kivelä T.

Invest Ophthalmol Vis Sci. 2003 Nov;44(11):4651-9.

PMID:
14578381
11.

Prognostic factors for survival after enucleation for choroidal and ciliary body melanomas.

Isager P, Ehlers N, Overgaard J.

Acta Ophthalmol Scand. 2004 Oct;82(5):517-25.

12.

Uveal melanoma survival in Sweden from 1960 to 1998.

Bergman L, Seregard S, Nilsson B, Lundell G, Ringborg U, Ragnarsson-Olding B.

Invest Ophthalmol Vis Sci. 2003 Aug;44(8):3282-7.

PMID:
12882771
13.

External Validation of the Liverpool Uveal Melanoma Prognosticator Online.

DeParis SW, Taktak A, Eleuteri A, Enanoria W, Heimann H, Coupland SE, Damato B.

Invest Ophthalmol Vis Sci. 2016 Nov 1;57(14):6116-6122. doi: 10.1167/iovs.16-19654.

PMID:
27835710
14.

[Age distribution of uveal melanoma and its relationship to survival].

Graell X, Caminal JM, Masuet C, Arias L, Rubio M, Pujol O, Roca G, Arruga J.

Arch Soc Esp Oftalmol. 2007 Jun;82(6):343-7. Spanish.

15.
16.

Local Recurrence Significantly Increases the Risk of Metastatic Uveal Melanoma.

Ophthalmic Oncology Task Force.

Ophthalmology. 2016 Jan;123(1):86-91. doi: 10.1016/j.ophtha.2015.09.014. Epub 2015 Oct 21.

17.

Survival after proton-beam irradiation of uveal melanomas.

Kodjikian L, Roy P, Rouberol F, Garweg JG, Chauvel P, Manon L, Jean-Louis B, Little RE, Sasco AJ, Grange JD.

Am J Ophthalmol. 2004 Jun;137(6):1002-10.

PMID:
15183783
18.

American Joint Committee on Cancer classification of posterior uveal melanoma (tumor size category) predicts prognosis in 7731 patients.

Shields CL, Kaliki S, Furuta M, Fulco E, Alarcon C, Shields JA.

Ophthalmology. 2013 Oct;120(10):2066-71. doi: 10.1016/j.ophtha.2013.03.012. Epub 2013 May 9.

PMID:
23664467
19.

Uveal Metastasis: Clinical Features and Survival Outcome of 2214 Tumors in 1111 Patients Based on Primary Tumor Origin.

Shields CL, Welch RJ, Malik K, Acaba-Berrocal LA, Selzer EB, Newman JH, Mayro EL, Constantinescu AB, Spencer MA, McGarrey MP, Knapp AN, Graf AE, Altman AJ, Considine SP, Shields JA.

Middle East Afr J Ophthalmol. 2018 Apr-Jun;25(2):81-90. doi: 10.4103/meajo.MEAJO_6_18.

20.

Relative survival rates after alternative therapies for uveal melanoma.

Seddon JM, Gragoudas ES, Egan KM, Glynn RJ, Howard S, Fante RG, Albert DM.

Ophthalmology. 1990 Jun;97(6):769-77.

PMID:
2374681

Supplemental Content

Support Center